|
1
|
Weller M, Butowski N, Tran DD, Recht LD,
Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, et al:
Rindopepimut with temozolomide for patients with newly diagnosed,
EGFRvIII-expressing glioblastoma (ACT IV): A randomised,
double-blind, international phase 3 trial. Lancet Oncol.
18:1373–1385. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blumenthal DT, Rankin C, Stelzer KJ,
Spence AM, Sloan AE, Moore DF Jr, Padula GD, Schulman SB, Wade ML
and Rushing EJ: A Phase III study of radiation therapy (RT) and
O6-benzylguanine + BCNU versus RT and BCNU alone and
methylation status in newly diagnosed glioblastoma and gliosarcoma:
Southwest Oncology Group (SWOG) study S0001. Int J Clin Oncol.
20:650–658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pollack IF, Jakacki RI, Butterfield LH,
Hamilton RL, Panigrahy A, Potter DM, Connelly AK, Dibridge SA,
Whiteside TL and Okada H: Antigen-specific immune responses and
clinical outcome after vaccination with glioma-associated antigen
peptides and polyinosinic-polycytidylic acid stabilized by lysine
and carboxymethylcellulose in children with newly diagnosed
malignant brainstem and nonbrainstem gliomas. J Clin Oncol.
32:2050–2058. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eisenstat DD, Pollack IF, Demers A, Sapp
MV, Lambert P, Weisfeld-Adams JD, Burger PC, Gilles F, Davis RL,
Packer R, et al: Impact of tumor location and pathological
discordance on survival of children with midline high-grade gliomas
treated on Children's Cancer Group high-grade glioma study CCG-945.
J Neurooncol. 121:573–581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan H, Wang W, Dou C, Tian F and Qi S:
Securin promotes migration and invasion via matrix
metalloproteinases in glioma cells. Oncol Lett. 9:2895–2901. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bister VO, Salmela MT,
Karjalainen-Lindsberg ML, Uria J, Lohi J, Puolakkainen P,
Lopez-Otin C and Saarialho-Kere U: Differential expression of three
matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal
and inflamed intestine and colon cancer. Dig Dis Sci. 49:653–661.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marchenko GN and Strongin AY: MMP-28, a
new human matrix metalloproteinase with an unusual cysteine-switch
sequence is widely expressed in tumors. Gene. 265:87–93. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan YB, Zhang CH, Wang SQ, Ai PH, Chen K,
Zhu L, Sun ZL and Feng DF: Transforming growth factor beta induced
(TGFBI) is a potential signature gene for mesenchymal subtype
high-grade glioma. J Neurooncol. 137:395–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo Z, Li G, Bian E, Ma CC, Wan J and Zhao
B: TGF-β-mediated repression of MST1 by DNMT1 promotes glioma
malignancy. Biomed Pharmacother. 94:774–780. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suomela S, Koljonen V, Skoog T, Kukko H,
Böhling T and Saarialho-Kere U: Expression of MMP-10, MMP-21,
MMP-26, and MMP-28 in Merkel cell carcinoma. Virchows Arch.
455:495–503. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gencer S, Cebeci A and Irmak-Yazicioglu
MB: Matrix metalloproteinase gene expressions might be oxidative
stress targets in gastric cancer cell lines. Chin J Cancer Res.
25:322–333. 2013.PubMed/NCBI
|
|
13
|
Manicone AM, Gharib SA, Gong KQ, Eddy WE,
Long ME, Frevert CW, Altemeier WA, Parks WC and Houghton AM: Matrix
metalloproteinase-28 is a key contributor to emphysema
pathogenesis. Am J Pathol. 187:1288–1300. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Illman SA, Lohi J and Keski-Oja J:
Epilysin (MMP-28)-structure, expression and potential functions.
Exp Dermatol. 17:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Illman SA, Lehti K, Keski-Oja J and Lohi
J: Epilysin (MMP-28) induces TGF-beta mediated epithelial to
mesenchymal transition in lung carcinoma cells. J Cell Sci.
119:3856–3865. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rao S, Zaidi S, Banerjee J, Jogunoori W,
Sebastian R, Mishra B, Nguyen BN, Wu RC, White J, Deng C, et al:
Transforming growth factor-β in liver cancer stem cells and
regeneration. Hepatol Commun. 1:477–493. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Åström P, Juurikka K, Hadler-Olsen ES,
Svineng G, Cervigne NK, Coletta RD, Risteli J, Kauppila JH, Skarp
S, Kuttner S, et al: The interplay of matrix metalloproteinase-8,
transforming growth factor-β1 and vascular endothelial growth
factor-C cooperatively contributes to the aggressiveness of oral
tongue squamous cell carcinoma. Br J Cancer. 117:1007–1016. 2017.
View Article : Google Scholar : PubMed/NCBI
|
